This contract expires in 116 days (Sep 30, 2026).

Browse related active opportunities

FIRM FIXED PRICE

MCKESSON CORPORATION - B1 MCKESSON REGULAR MEDICATION PERIOD OF PERFORMANCE FY26.

PIID: 15BH0N26F00000032
Signed Date: Dec 31, 2025Effective Date: Oct 1, 2025End Date: Closes in 116 days
Award $
$25K
Vendor
MCKESSON CORPORATION
NAICS
325412
Signed Date
Dec 31, 2025

Key Details

Dollars Obligated
$25,000
Base & All Options
$25,000
Awarding Agency
Department of Justice
Awarding Sub-Agency
Federal Prison System / Bureau of Prisons
Product Service Code
Q517 - PHARMACY SERVICES
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
IRVING, TX, 750392402, CD-TX-33

Description

B1 MCKESSON REGULAR MEDICATION PERIOD OF PERFORMANCE FY26.

Context & Analysis

On Dec 31, 2025, Department of Justice obligated $25,000 to MCKESSON CORPORATION for b1 mckesson regular medication period of performance fy26.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in IRVING, TX. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Justice under NAICS 325412 — related awards are listed below.

Contractor Information

UEI: S1RUKWWRYFL6
CAGE Code: 1MKG3
Location: IRVING, TX
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related